Clinical Study
Mediteanox® and Pomanox®: Cardiovascular Health evidence
A Spanish Government-supported 20 week clinical trial investigated properties of heart-friendly Mediterranean diet olive and pomegranate polyphenols (Mediteanox® and Pomanox®) on early atherosclerosis markers in 67 seemingly healthy participants.
From the results of the authoritative study, Dr Quirós-Fernández and co-authors conclude that standardized amounts of polyphenols as Pomanox® and Mediteanox®, improved endothelial function, blood pressure and circulating oxLDL, especially in subjects with altered parameters.
According to the authors, regular intake may help reduce cardiovascular risk.
